FDA Panel Questions Safety of SSRIs During Pregnancy
TL;DR Summary
A recent FDA panel raised concerns about the safety of SSRIs during pregnancy, but many doctors and health organizations argue that the panel's claims are misleading and based on poor-quality evidence, emphasizing that most SSRIs are safe and that untreated mental health issues pose significant risks to both mother and baby.
- An FDA panel spread misinformation about SSRI use in pregnancy. Doctors are concerned NPR
- F.D.A. Panel Debates ‘Black Box’ Warning for Antidepressants in Pregnancy The New York Times
- An unusual FDA panel on antidepressant use during pregnancy elevated skeptics of the drugs statnews.com
- Millions of Americans Need These Drugs. RFK Jr.’s Minions Have Them in Their Crosshairs. Slate Magazine
- FDA Panel Casts Doubt on Safety of SSRI Use in Pregnancy Medscape
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
4 min
vs 5 min read
Condensed
94%
901 → 51 words
Want the full story? Read the original article
Read on NPR